Surgery
Volume 133, Issue 1 , Pages 81-90 , January 2003

Is ischemic preconditioning of the kidney clinically relevant?

,Accepted 19 July 2002.

References 

  1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136
  2. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 1992;263:H1107–H1112
  3. Iwamoto T, Miura T, Adachi T, Noto T, Ogawa T, Tsuchida A, et al.  Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free-radical scavengers in the rabbit. Circulation. 1991;83:1015–1022
  4. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, et al.  Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 1991;84:2495–2503
  5. Wu ZK, Pehkonen E, Laurikka J, Kaukinen L, Honkonen EL, Kuakinen S, et al.  Protective effect of unstable angina in coronary artery bypass surgery. Scand Cardiovasc J. 2000;34:486–492
  6. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T, et al.  Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med. 1996;128:251–258
  7. Kato H, Liu Y, Kogure K, Kato K. Induction of 27-kDa heat shock protein following cerebral ischemia in a rat model of ischemic tolerance. Brain Res. 1994;634:235–244
  8. Hotter G, Closa D, Prados M, Fernandez-Cruz L, Prats N, Gelpi E, et al.  Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun. 1996;222:27–32
  9. Jerome SN, Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged I/R. Am J Physiol. 1995;268:H2063–H2067
  10. Heller JA, Weinberg A, Arons R, Krishnasastry KV, Lyon RT, Deitch JS, et al.  Two decades of abdominal aortic aneurysm repair: have we made any progress?. J Vasc Surg. 2000;32:1091–1100
  11. Barratt J, Parajasingam R, Sayers RD, Feehally J. Outcome of acute renal failure following surgical repair of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2000;20:163–168
  12. Toosy N, McMorris EL, Grace PA, Mathie RT. Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int. 1999;84:489–494
  13. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem. 2001;276:11870–11876
  14. Turman MA, Bates CM. Susceptibility of human proximal tubular cells to hypoxia: effect of hypoxic preconditioning and comparison to glomerular cells. Ren Fail. 1997;19:47–60
  15. Behrends M, Walz MK, Kribben A, Neumann T, Helmchen U, Philipp T, et al.  No protection of the porcine kidney by ischaemic preconditioning. Exp Physiol. 2000;85:819–827
  16. Arend LJ, Thompson CI, Spielman WS. Dipyridamole decreases glomerular filtration in the sodium-depleted dog. Evidence for mediation by intrarenal adenosine. Circ Res. 1985;56:242–251
  17. Saunder A, Ametani MS, Belzer FO, Southard JH. Cytoprotective effect of glycine in cold stored canine renal tubules. Cryobiology. 1993;30:243–249
  18. Weinberg JM, Davis JA, Abarzua M, Rajan T. Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. J Clin Invest. 1987;80:1446–1454
  19. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors. Am J Physiol Renal Physiol. 2000;278:F380–F387
  20. Drabkin DL, Austin JH. Spectrophotometric studies II: preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem. 1935;112:51
  21. Liu Y, Gao WD, O'Rourke B, Marban E. Cell-type specificity of preconditioning in an in vitro model. Basic Res Cardiol. 1996;91:450–457
  22. Jefayri MK, Grace PA, Mathie RT. Attenuation of reperfusion injury by renal ischaemic preconditioning: the role of nitric oxide. BJU Int. 2000;85:1007–1013
  23. Cochrane J, Williams BT, Banerjee A, Harken AH, Burke TJ, Cairns SB, et al.  Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Ren Fail. 1999;21:135–145
  24. Islam CF, Mathie RT, Dinneen MD, Kiely EA, Peters AM, Grace PA. Ischaemia-reperfusion injury in the rat kidney: the effect of preconditioning. Br J Urol. 1997;79:842–847
  25. Pagliaro P, Gattullo D, Rastaldo R, Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sci. 2001;69:1–15
  26. Mockridge JW, Punn A, Latchman DS, Marber MS, Heads RJ. PKC-dependent delayed metabolic preconditioning is independent of transient MAPK activation. Am J Physiol Heart Circ Physiol. 2000;279:H492–H501
  27. Gaudette GR, Krukenkamp IB, Saltman AE, Horimoto H, Levitsky S. Preconditioning with PKC and the ATP-sensitive potassium channels: a codependent relationship [see comments]. Ann Thorac Surg. 2000;70:602–608
  28. Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol. 2000;32:1159–1167
  29. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol. 1997;29:207–216
  30. Das DK, Maulik N, Sato M, Ray PS. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem. 1999;196:59–67
  31. Tanaka M, Fujiwara H, Yamasaki K, Yokota R, Doyama K, Inada T, et al.  Expression of heat shock protein after ischemic preconditioning in rabbit hearts. Jpn Circ J. 1998;62:512–516
  32. Sakura H, Ammala C, Smith PA, Gribble FM, Ashcroft FM. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle. FEBS Lett. 1995;377:338–344
  33. Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, Butcher SP. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. Br J Pharmacol. 1997;122:1202–1208
  34. Li G, Chen S, Lou W, Lu E. Protective effects of ischemic preconditioning on donor lung in canine lung transplantation. Chest. 1998;113:1356–1359
  35. Southard JH, Belzer FO. Organ preservation. Annu Rev Med. 1995;46:235–247

☆ Supported by a grant from the Public Health Service (National Institutes of Health) DK-44254.

☆☆ Reprint requests: Martin J. Mangino, PhD, Department of Surgery, Division of Organ Transplantation, University of Wisconsin Hospital and Clinics, H4/333 Clinical Science Center, 600 Highland Ave, Madison, WI 53792.

★ 0039-6060/2003/$30.00 + 0

PII: S0039-6060(02)21693-1

doi: 10.1067/msy.2003.93

Surgery
Volume 133, Issue 1 , Pages 81-90 , January 2003

Article Tools

* Image Usage & Resolution